CONFLUENCE DISCOVERY TECHNOLOGIES

Confluence Discovery Technologies is an indirectly wholly owned subsidiary of Aclaris Therapeutics, Inc. (NASDAQ:ACRS). Aclaris is a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology and immunology... Confluence Discovery Technologies, Inc., an indirectly wholly owned subsidiary of Aclaris Therapeutics, Inc., serves as research partners for pharma and biotech companies in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, in vivo efficacy models and medicinal chemistry. We specialize in drug discovery research on complex biological systems, challenging drug targets, immuno-oncology and preclinical and clinical biomarker development... Avoid Pitfalls Costly Delays Quality Research Partner from Idea to IND Our expert drug discovery scientists help meet milestones and expedite your timeline to reaching development candidate,..

Also known as: Confluence Discovery Technologies, Inc.

Primary location: St. Louis United States